Found 97 matching trials
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL) PHASE1 The researchers are doing this study to see if alectinib in combination wit...
Show More Location
Memorial Sloan Kettering Basking Ridge (LimitedProtocol Activities)
Learn More & Join Trial
Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms PHASE2 Explore the relationship between drug target ALK gene single nucleotide pol...
Show More Status
Active Not Recruiting
Location
Omnicure Clinical Research
Learn More & Join Trial
The Food-effect on Alectinib Pharmacokinetics NA The goal of this food-effect study on Alectinib pharmacokinetics is to lear...
Show More Location
Netherlands Cancer Institute
Learn More & Join Trial
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study PHASE3 This is an open-label, multicenter, extension study. Patients who are recei...
Show More Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Learn More & Join Trial
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs PHASE2 This is a prospective non-randomized national clinical phase 2 trial that a...
Show More Location
Turku University Hospital Cancer Centre
Learn More & Join Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors PHASE2 This multicenter, non-randomized, open-label study will evaluate the effica...
Show More Location
Western Regional Medical Center at Cancer Treatment Centers of America
Learn More & Join Trial
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements PHASE1 This study will consist of a Phase 1b and Phase 2 portion. The Phase 1b por...
Show More Location
Stanford University
Learn More & Join Trial
Improving Public Cancer Care by Implementing Precision Medicine in Norway PHASE2 IMPRESS-Norway is a prospective, non-randomized clinical trial evaluating e...
Show More Location
Sykehuset Ålesund
Learn More & Join Trial
A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) PHASE1 This non-randomized, open-label, multicenter study will evaluate the safety...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers PHASE2 This clinical trial is looking at a drug called alectinib. Alectinib is app...
Show More Location
Belfast City Hospital
Learn More & Join Trial